Importantly, we found that Lac-EVs (2.5 μg/mL) significantly induced the production of IL-10 in LPS-stimulated MG cells, indicating that Lac-EVs may regulate the immune process in MG by adjusting the production of IL-10 (Fig. 4C). Here, LCT is linked to myasthenia gravis.